Cargando…
Palindromic amplification of the ERBB2 oncogene in primary HER2-positive breast tumors
Oncogene amplification confers a growth advantage to tumor cells for clonal expansion. There are several, recurrently amplified oncogenes throughout the human genome. However, it remains unclear whether this recurrent amplification is solely a manifestation of increased fitness resulting from random...
Autores principales: | Marotta, Michael, Onodera, Taku, Johnson, Jeffrey, Budd, G. Thomas, Watanabe, Takaaki, Cui, Xiaojiang, Giuliano, Armando E., Niida, Atsushi, Tanaka, Hisashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314454/ https://www.ncbi.nlm.nih.gov/pubmed/28211519 http://dx.doi.org/10.1038/srep41921 |
Ejemplares similares
-
A common copy-number breakpoint of ERBB2 amplification in breast cancer colocalizes with a complex block of segmental duplications
por: Marotta, Michael, et al.
Publicado: (2012) -
Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3
por: Ross, Jeffrey S., et al.
Publicado: (2018) -
erbB-2 antisense oligonucleotides inhibit the proliferation of breast carcinoma cells with erbB-2 oncogene amplification.
por: Colomer, R., et al.
Publicado: (1994) -
Precision Medicine in Metastatic Colorectal Cancer: Targeting ERBB2 (HER-2) Oncogene
por: Torres-Jiménez, Javier, et al.
Publicado: (2022) -
HER-2/neu oncogene: what does amplification mean?
por: Pavy, J. J., et al.
Publicado: (1993)